BioSpace News Archive

NuVasive, Inc. (NASDAQ: NUVA), procedurally integrated solutions announced today that the Company’s SpineTRACK Registry submitted successful quality performance data to the Centers of Medicare & Medicaid Services (CMS) on behalf of healthcare providers at Southern Oregon Neurosurgical & Spine Associates (SONSA) for the Merit-based Incentive Payment System (MIPS).

Joint conference addresses cutting-edge science and technology for patient care including treatment of pain, disease, neurological and psychiatric disorders

The Texas Mesothelioma Victims Center says, “If you are a power plant, energy worker or a Navy Veteran with mesothelioma anywhere in Texas and you have just been diagnosed with mesothelioma please call us anytime at 800-714-0303 for on the spot access to the amazing attorneys at the law firm of Karst von Oiste who specialize in helping people like-you-and their goal is the best compensation results for their clients.

Agreement expands reach of industry-leading Horizon DXA system

PureTech Health plc. announced that Daphne Zohar, founder and chief executive officer, will present at the Jefferies 2019 Healthcare Conference in New York City on Wednesday, June 5, at 11:30 AM EDT.

Achieve Life Sciences, Inc. announced that the United States Patent and Trademark Office has granted Achieve a patent on succinate salt of cytisinicline and use thereof.

Ping An Insurance Company of China, Ltd. is pleased to announce that the subsidiary Ping An International Smart City Technology Co., Ltd., has signed a research agreement with the Medical Artificial Intelligence Lab Program of the Department of Diagnostic Radiology at the University of Hong Kong to clinically evaluate their artificial intelligence based optical coherence tomography[1] retinal disease[2] screening system.

Ametros has promoted Nicole Sauk to Chief Financial Officer.

TFF Pharmaceuticals, Inc. announced it has closed an $8.17 million offering of Series A Preferred Stock.

Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that it has entered into a strategic collaboration with Debiopharm for the development of a companion diagnostic (CDx) test using its newly-launched Whole Transcriptome Sequencing (WTS) assay for mRNA analysis called MI Transcriptome™